Salcit Technologies, an India-based respiratory healthcare company, has joined forces with the Google Research team to explore how Google’s Health Acoustic Representations (HeAR), can help expand the capabilities of Salcit’s bioacoustic AI technology Swaasa.
Swaasa uses HeAR to help research and enhance early detection of tuberculosis based on cough sounds.
“Every missed case of tuberculosis is a...
Community health centres, or puskesmas, in the Indonesian province of West Java, south of capital Jakarta, will leverage generative AI to augment their capabilities to address critical health issues.
The Sumedang regency recently tied up with Singaporean doctors' networking platform Docquity to develop and launch the genAI-powered virtual assistant called TehAI.
HOW IT WORKS
TehAI reportedly...
Indian biotech company Mylab Discovery Solutions is integrating Qure.ai's AI technology into its upcoming x-ray device for screening tuberculosis.
According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by Qure.ai's deep-learning software qXR to analyse chest x-ray images and identify TB within a minute...
VinBrain, an artificial intelligence healthcare software developer in Vietnam, recently came up with an AI model for the diagnosis and screening of tuberculosis.
The Vingroup-backed company has worked with the German non-profit group Friends for International Tuberculosis Relief in writing a white paper discussing the utilisation of AI in TB diagnosis and screening in the country.
WHY IT MATTERS...
South Korea’s AI-based medical analysis solutions company, JLK Inspection, announced the recent signing of an agreement with the Clinton Health Access Initiative (CHAI) in Lao PDR, a US based INGO to support the Lao PDR National TB Center (NTC) in strengthening and expanding access to tuberculosis screening via AI enabled CXR reading.
CHAI is a global health organization committed to saving lives...
Proteus Digital Health’s ingestible pill and sensor system could improve medication adherence, and subsequently treatment, for patients with tuberculosis (TB), according to new data from an independent study conducted in California.
Published Friday in PLoS Medicine, the trial found Proteus’ system to accurately determine whether or not a medication was taken. Patients using the system at home...
Replacing the frequent home visits often necessary for tuberculosis treatment with video visits facilitated by an app appears to be a cost-effective, well-received means of ensuring adherence throughout therapy, according to a recently published pilot study.
Because TB is, airborne, highly infectious, and increasingly resistant to antibiotics, treatment and prevention of the disease often...
Health app developer emocha, which stands for electronic mobile comprehensive health application, has partnered with the Baltimore City Health Department to run a pilot on medication adherence for patients with tuberculosis.
The Baltimore City Health Department will use emocha's app, miDOT, which stands for mobile indirect observational therapy, in the pilot.
The miDOT app will record videos of...
Pharmaceutical giant Novartis announced that would invest $24M in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus Biomedical's sensing technology for organ transplantation. (That must be the kind of exclusive deal Novartis had in mind when the two companies announced their collaboration on a pilot last year.)
As part of the deal,...
"We really see such a huge opportunity here," said Claire Thwaites, head of the Vodafone Foundation and United Nations Foundation partnership. "There are 2.2 billion mobile phones in emerging markets and such a low number of PCs [only 305 million]. The number of healthcare workers and hospital beds are very, very low too. Mobile networks, of course, can be deployed much more easily than can fixed...
